Escherichia coli Nissle 1917 as adjuvant therapy in patients with chronic bacterial prostatitis: a non-blinded, randomized, controlled trial.

Celeste ManfrediFrancesco Paolo CalaceFerdinando FuscoCarmelo QuattroneDario GiordanoFelice CrocettoMassimiliano CretaMarco De SioDavide Arcaniolo

Published in: World journal of urology (2021)

Combination therapy with EcN and levofloxacin allows a better control of symptoms and biological recurrences in patients with CBP, without worsening the safety of the treatment.

Keyphrases

combination therapy
randomized controlled trial
escherichia coli
study protocol
clinical trial
staphylococcus aureus
sleep quality
pseudomonas aeruginosa
candida albicans